(Photo courtesy of Novartis)

Novartis Announces Broad Range of Initiatives to Respond to COVID-19 Pandemic and Creates $20 Million Global Fund to Support Impacted Communities

Originally published on novartis.com.

  • Novartis COVID-19 Response Fund will provide grants of up to USD 1 million to support communities around the world most impacted by the Coronavirus outbreak
  • Novartis to join collaborative R&D efforts with the Bill & Melinda Gates Foundation, Wellcome, and Mastercard -supported COVID-19 Therapeutics Accelerator and a partnership with the Innovative Medicines Initiative (IMI)
  • Commitments build on Sandoz pledge to maintain price stability of essential medicines and strong support of patients and healthcare systems
  • Company continues to maintain strong focus on protecting employee health, ensuring supply of medicines for patients and smooth clinical trial operations

Vas Narasimhan, CEO of Novartis, said: “We are dealing with an extraordinary and unprecedented public health crisis that requires an incredible level of involvement and collaboration across government, society and business. As a medicines company present in over 140 countries, we are stepping in to provide additional financial support to critical community or national programs that can help address urgent public health needs resulting from the COVID-19 pandemic. Recognizing the power of working together as an industry, we are also bringing the talent and capabilities of our industry-leading R&D organization to two leading and important collaborative R&D initiatives.”

Novartis today announced a broad set of measures to support the global response to the COVID-19 pandemic. These measures include the creation of a global fund to support communities around the world impacted by the COVID-19 pandemic as well as the company’s decision to join two key cross-industry R&D initiatives.

The Novartis COVID-19 Response Fund will provide USD 20 million in grants to support public health initiatives designed to help communities manage challenges posed by the pandemic. The company has established an accelerated global review process that will allow for quick approval and disbursement of individual grants of up to USD 1 million. The fund is open to grant applications that will be processed through Novartis affiliates in the countries. The fund will seek to provide financial grants for initiatives focused on but not limited to the following areas:

  • Strengthening local and national healthcare infrastructure including funding of additional medical personnel, sourcing of medicines and medical equipment
  • Establishing digital platforms for COVID-19 related data collection, remote delivery of healthcare and effective dissemination of important public health information
  • Creating new or enhancing new community health programs specific to the pandemic response

Research & Development Collaborations
Novartis has also entered new collaborative research efforts such as the COVID-19 Therapeutics Accelerator, coordinated by the Bill & Melinda Gates Foundation, Wellcome, and Mastercard, as well as a COVID-19 directed partnership organized by the Innovative Medicines Initiative (IMI).  Both are cross-sector collaborations that bring several pharmaceutical companies and expert academic institutions into coordinated research programs, with the aim of bringing the most promising molecules forward quickly without organizational barriers. Additionally, in response to an urgent call for research and development on coronavirus, issued by the European Federation of Pharmaceutical Industries and Associations (EFPIA), Novartis is contributing by making available several compounds from its libraries that are considered suitable for in vitro antiviral testing. In addition, the company is rapidly evaluating other existing products to see if any could be utilized beyond their approved indications in response to the pandemic.

Supporting Patients, Healthcare Providers and Systems
Earlier this month, Sandoz, the company’s generics and biosimilars division was the first company to commit to keeping prices stable for a basket of essential medicines that may help in the treatment of coronavirus cases, specifically antivirals to reduce the impact of coronavirus and antibiotics to combat pneumonia.

Furthermore, Novartis has been monitoring the global pandemic situation closely. The company’s primary concern has been the health and safety of associates and patients globally. Novartis continues to deliver its medicines to patients and healthcare providers around the world and does not anticipate supply chain disruption at this time given strong mitigation measures and inventory levels. The company has also activated mitigation plans to ensure ongoing drug supply and smooth operations for its over 500 clinical studies. As part of its efforts to protect employee health, effective Monday, March 16 2020, all Novartis associates within Europe, US and Canada are requested to work from home, with the exception of those working in laboratories, manufacturing sites and in the field. The company has also stepped up the utilization of digital engagement tools to support internal collaboration as well as outreach to healthcare professionals and customers.

Latest News

banks, key, U.S., TD, Wells Fargo

U.S. Bank, KeyBank, TD Bank and Wells Fargo Announce Efforts to Mitigate Financial Impact of COVID-19

The outbreak of the novel coronavirus (COVID-19) is affecting more than just the physical health of Americans and people around the world. As governments shut down nonessential businesses, the economy is taking an unprecedented blow. Individuals and small businesses are bearing much of the brunt. However, many large banking corporations,…

Kaiser Permanente Mental Health App Now Available to Members at No Cost

Originally published on about.kaiserpermanente.org.  myStrength app is part of Kaiser Permanente’s effort to provide valuable tools to support mental and emotional health, particularly during stressful times. As part of its commitment to offer members innovative ways to promote personal health and wellness, particularly during increasing levels of stress and anxiety,…

AT&T Believing in our COVID-19 First Responders

Originally posted on ATT.com AT&T supports first responders, medical personnel, responding to COVID-19 with nourishing meals  Across the country – and around the world – first responders and medical personnel are playing a critical role in helping care for their communities during the COVID-19 crisis. “First responders and medical personnel…

Humana Announces Health Care Provider Initiative to Help Ease Financial and Administrative Stress During Coronavirus Pandemic

Originally posted on Humana.com Leading health and well-being company Humana Inc., announced actions designed to help provide financial and administrative relief for the health care provider community facing unprecedented strain during the coronavirus pandemic. First, Humana is implementing simplified and expedited claims processing, in order to get reimbursement payments to providers…